Matthia A Karreman
Overview
Explore the profile of Matthia A Karreman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
514
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tetzlaff S, Reyhan E, Layer N, Bengtson C, Heuer A, Schroers J, et al.
Cell
. 2024 Dec;
188(2):390-411.e36.
PMID: 39644898
Glioblastomas are invasive brain tumors with high therapeutic resistance. Neuron-to-glioma synapses have been shown to promote glioblastoma progression. However, a characterization of tumor-connected neurons has been hampered by a lack...
2.
Messmer J, Thommek C, Piechutta M, Venkataramani V, Wehner R, Westphal D, et al.
Immunity
. 2024 Oct;
57(11):2688-2703.e11.
PMID: 39368486
To improve immunotherapy for brain tumors, it is important to determine the principal intracranial site of T cell recruitment from the bloodstream and their intracranial route to brain tumors. Using...
3.
Schlieper-Scherf S, Hebach N, Hausmann D, Azorin D, Hoffmann D, Horschitz S, et al.
J Neurooncol
. 2024 Aug;
170(1):139-151.
PMID: 39088157
Purpose: This study investigates the biological effect of Tumor Treating Fields (TTFields) on key drivers of glioblastoma's malignancy-tumor microtube (TM) formation-and on the function and overall integrity of the tumor...
4.
Roesler J, Spitzer D, Jia X, Aasen S, Sommer K, Roller B, et al.
Neuro Oncol
. 2024 Jun;
26(11):2084-2099.
PMID: 38831719
Background: Brain metastases (BM) constitute an increasing challenge in oncology due to their impact on neurological function, limited treatment options, and poor prognosis. BM occurs through extravasation of circulating tumor...
5.
Karreman M, Bauer A, Solecki G, Berghoff A, Mayer C, Frey K, et al.
Cancer Res
. 2023 Jan;
83(8):1299-1314.
PMID: 36652557
Significance: Tracking single extravasating cancer cells using multimodal correlative microscopy uncovers a brain seeding mechanism involving endothelial remodeling driven by cancer cell-derived MMP9, which might enable the development of approaches...
6.
Hausmann D, Hoffmann D, Venkataramani V, Jung E, Horschitz S, Tetzlaff S, et al.
Nature
. 2022 Dec;
613(7942):179-186.
PMID: 36517594
Diffuse gliomas, particularly glioblastomas, are incurable brain tumours. They are characterized by networks of interconnected brain tumour cells that communicate via Ca transients. However, the networks' architecture and communication strategy...
7.
Tehranian C, Fankhauser L, Harter P, Ratcliffe C, Zeiner P, Messmer J, et al.
Neuro Oncol
. 2021 Jul;
24(2):213-225.
PMID: 34216217
Background: Brain metastases (BM) are a frequent complication of malignant melanoma (MM), with limited treatment options and poor survival. Prevention of BM could be more effective and better tolerated than...
8.
Berghoff A, Liao Y, Karreman M, Ilhan-Mutlu A, Gunkel K, Sprick M, et al.
Mol Cancer Res
. 2021 Jan;
19(4):688-701.
PMID: 33443114
Specific biological properties of those circulating cancer cells that are the origin of brain metastases (BM) are not well understood. Here, single circulating breast cancer cells were fate-tracked during all...
9.
Feinauer M, Schneider S, Berghoff A, Robador J, Tehranian C, Karreman M, et al.
Blood
. 2020 Dec;
137(9):1219-1232.
PMID: 33270819
Clinically relevant brain metastases (BMs) frequently form in cancer patients, with limited options for effective treatment. Circulating cancer cells must first permanently arrest in brain microvessels to colonize the brain,...
10.
Kovalchuk B, Berghoff A, Karreman M, Frey K, Piechutta M, Fischer M, et al.
Clin Exp Metastasis
. 2020 Sep;
37(6):637-648.
PMID: 32918638
Brain metastases (BM) are an ever-increasing challenge in oncology, threatening quality of life and survival of many cancer patients. The majority of BM originate from lung adenocarcinoma, and stage III...